EXPERIMENTAL PATHOLOGY

实验病理学

基本信息

项目摘要

The overall objectives of the Experimental Pathology Shared Resource are to provide NYUCI investigators with quality-controlled, stable and cost-effective services and expertise for the microscopic analysis of human and animal tissues. It is divided into two laboratories: 1) Histopathology and 2) Immunohistochemistry. The Histopathology laboratory provides routine histopathologic services, including tissue preparation, processing, embedding, sectioning and histochemical staining for paraffin and cryoembedded tissues. The Histopathology laboratory also provides whole slide digital imaging and basic microscopy services, and it makes available state-of-the art instrumentation, such as a laser microdissection system. The main role of the Immunohistochemistry laboratory is to develop immunohistochemical protocols for new antibodies (commercial or proprietary) that have not been tested in fresh, frozen or fixed human or animal tissues and cells. It also serves as an immunohistochemical antibody repository with a catalog of over 900 commercial and proprietary antibodies, which is published on the laboratory website. Both laboratories offer one-on-one training as well as formal teaching modules for the Pathobiology and Translational Medicine Graduate Training program and mini-rotations for medical students. The Experimental Pathology laboratories are uniquely positioned as a
实验病理学共享资源的总体目标是为Nyuci研究人员提供质量控制,稳定且具有成本效益的服务以及对人类组织和动物组织的微观分析的专业知识。它分为两个实验室:1)组织病理学和2)免疫组织化学。组织病理学实验室提供常规的组织病理学服务,包括用于石蜡和冷冻组织的组织制备,加工,嵌入,切片和组织化学染色。组织病理学实验室还提供整个幻灯片数字成像和基本显微镜服务,并且可以提供最新的仪器,例如激光显微解剖系统。免疫组织化学实验室的主要作用是开发用于新抗体(商业或专有)的免疫组织化学方案,这些方案尚未在新鲜,冷冻或固定的人类或动物组织和细胞中进行测试。它也是一种免疫组织化学抗体存储库,并具有900多种商业和专有抗体的目录,该目录发表在实验室网站上。这两个实验室都为病理生物学和转化医学研究生培训计划以及医学生的小型培训提供一对一的培训以及正式的教学模块。实验病理实验室被唯一地定位为

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William L. Carroll其他文献

The Role of over-Expressed β <em>Globin</em> in Driving Relapsed B - Cell Acute Lymphoblastic Leukemia (B-ALL)
  • DOI:
    10.1182/blood-2023-180976
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jessica Krugman;Sylwia Jasinski;Elizabeth A. Raetz;Nikki Evensen;William L. Carroll
  • 通讯作者:
    William L. Carroll
Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231
  • DOI:
    10.1182/blood-2023-190141
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Susan I. Colace;Meenakshi Devidas;Zhiguo (Bruce) Chen;Robert J. Hayashi;Brent L. Wood;Natia Esiashvili;Samir Patel;Andrew J Carroll;Nyla A. Heerema;Barbara Asselin;Karen R. Rabin;Patrick A. Zweidler-McKay;Elizabeth A. Raetz;Mignon L. Loh;Naomi J. Winick;William L. Carroll;David T. Teachey;Stuart S. Winter;Kimberly P. Dunsmore
  • 通讯作者:
    Kimberly P. Dunsmore
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
  • DOI:
    10.1182/blood-2024-194872
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Etan Orgel;Michael J. Burke;John A. Kairalla;Emily Hibbitts;Meenakshi Devidas;Michael J. Borowitz;Brent L. Wood;Nyla A. Heerema;Andrew J. Carroll;Kelly Maloney;Leonard A. Mattano;Anne Angiolillo;Eric C. Larsen;Wanda L. Salzer;David T. Teachey;Naomi J. Winick;William L. Carroll;Stephen P. Hunger;Elizabeth A. Raetz;Mignon L. Loh
  • 通讯作者:
    Mignon L. Loh
<em>Subtype Dependent Drug Resistance Alterations in Relapsed Childhood B-ALL: A Children's Oncology Group Study</em>
  • DOI:
    10.1182/blood-2022-166489
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Xiaotu Ma;Lingyun Ji;Yanling Liu;Ying Shao;Heather Mulder;Pandurang Kolekar;Quang Tran;Jinghui Zhang;John Easton;William L. Carroll;Patrick A. Brown;Mignon L. Loh
  • 通讯作者:
    Mignon L. Loh
Patients with Down Syndrome and High-Risk B-Acute Lymphoblastic Leukemia Demonstrate Improved Outcomes on a Modified Chemotherapy Regimen: A Report from Children's Oncology Group Study AALL1131
  • DOI:
    10.1182/blood-2023-185368
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Vilmarie Rodriguez;Meenakshi Devidas;Zhiguo (Bruce) Chen;Andrew J Carroll;Nyla A. Heerema;Michael J. Borowitz;Brent L. Wood;William L. Carroll;Naomi J Winick;Elizabeth A. Raetz;Mignon L. Loh;Michael J. Burke;Wanda L. Salzer;Stephen P. Hunger;Karen R. Rabin
  • 通讯作者:
    Karen R. Rabin

William L. Carroll的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William L. Carroll', 18)}}的其他基金

Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
  • 批准号:
    10381569
  • 财政年份:
    2021
  • 资助金额:
    $ 7.03万
  • 项目类别:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
  • 批准号:
    10184002
  • 财政年份:
    2021
  • 资助金额:
    $ 7.03万
  • 项目类别:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
  • 批准号:
    10631888
  • 财政年份:
    2021
  • 资助金额:
    $ 7.03万
  • 项目类别:
BIOMEDICAL INFORMATICS
生物医学信息学
  • 批准号:
    8436451
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:
PROTEOMICS
蛋白质组学
  • 批准号:
    8436447
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:
DEVELOPMENTAL FUNDS
发展基金
  • 批准号:
    8436459
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:
EPIDEMIOLOGY AND CANCER CONTROL
流行病学和癌症控制
  • 批准号:
    8436432
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:
FLOW CYTOMETRY AND CELL SORTING
流式细胞术和细胞分选
  • 批准号:
    8436444
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:
DATA AND SAFETY MONITORING
数据和安全监控
  • 批准号:
    8436456
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:
BIOREPOSITORY CENTER
生物样本库中心
  • 批准号:
    8436441
  • 财政年份:
    2013
  • 资助金额:
    $ 7.03万
  • 项目类别:

相似海外基金

Clinical Cell Processing and Cell Culture
临床细胞处理和细胞培养
  • 批准号:
    8180925
  • 财政年份:
    2010
  • 资助金额:
    $ 7.03万
  • 项目类别:
Minority Student Development Program at Northern Arizona University
北亚利桑那大学少数民族学生发展计划
  • 批准号:
    7214789
  • 财政年份:
    1998
  • 资助金额:
    $ 7.03万
  • 项目类别:
Minority Student Development Program at Northern Arizona University
北亚利桑那大学少数民族学生发展计划
  • 批准号:
    7428796
  • 财政年份:
    1998
  • 资助金额:
    $ 7.03万
  • 项目类别:
Biorepository and Histopathology
生物样本库和组织病理学
  • 批准号:
    10580675
  • 财政年份:
    1997
  • 资助金额:
    $ 7.03万
  • 项目类别:
Antibody Production Shared Resource
抗体生产共享资源
  • 批准号:
    8934376
  • 财政年份:
    1997
  • 资助金额:
    $ 7.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了